This is a limited company view. Sign up for a Free Trial to see everything.

Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections.

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Switzerland

Founded

2006

Employees

8

Stage

Series B

Total funding

$10M

Last funding

9 years ago

Acquisitions

0

Growth score

0

Mindshare score

0

Scoring

Deals

$10.0M Series B

Mar 12, 2009

Employee Growth

Use Kenta Biotech's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Kenta Biotech's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Clinical Development Manager
Assistentin der Geschäftsleitung
Head Business Development
Energi consultant

Similar Companies

Esperance Pharmaceuticals

This is the home page's excerpt
Series C|10 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes